The Worldwide Leukapheresis Industry is Expected to Reach $133.9 Million by 2028

·8 min read

Dublin, Sept. 27, 2021 (GLOBE NEWSWIRE) -- The "Global Leukapheresis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User" report has been added to ResearchAndMarkets.com's offering.

The leukapheresis market is expected to reach US$ 133.90 million by 2028 from US$ 74.48 million in 2021; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028. The growth of the leukapheresis market is primarily attributed to the rising number of voluntary blood donors, rising incidence of hematologic diseases, and the surging elderly population. However, the high cost of leukapheresis obstructs the growth of the market to a certain extent.

Leukapheresis is a procedure that has white blood cells (leukocytes) involved in the body's immune response are segregated from a blood sample. It is a particular form of apheresis in which an element of blood, such as red blood cells or platelets, is obtained while the remaining blood is restored to circulation. Leukapheresis is often used to reduce very high white blood cell (WBC) counts, such as chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be completed to obtain white blood cells for later transplant, such as to manage abrupt declines in WBC counts throughout cancer chemotherapy. Another use is as a section of a novel form of immunotherapy, termed chimeric antigen receptor (CAR) T-cell therapy, to help fight leukemia, prostate cancer, and other forms of cancers. Leukapheresis can be completed on the person claiming treatment (autologous apheresis) or on a donor for a later transplant (allogeneic apheresis). Currently, leukapheresis is commonly used to treat various diseases, and it is also used for diagnostic purposes as it can increase circulating tumor cells yields.

Based on product type, the leukapheresis market is bifurcated into leukapheresis devices and leukapheresis disposables. In 2021, the leukapheresis disposables segment held a larger market share. However, the leukapheresis devices segment is expected to register a higher CAGR during 2021-2028. Based on application, the leukapheresis market is bifurcated into research applications and therapeutic applications. In 2021, the research applications segment held a larger share of the market and the same segment is expected to register a higher CAGR during the coming years. Based on end user, the leukapheresis market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, blood component providers and blood centers, and hospitals and transfusion centers.

Pharmaceutical and biotechnology companies, academic and research institutes, and manufacturing organizations are a few of the primary and secondary sources referred to while preparing the report on the leukapheresis market.

Reasons to buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the leukapheresis market.

  • Highlights key business priorities in order to assist companies to realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the global leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies.

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction

2. Leukapheresis Market - Key Takeaways

3. Research Methodology

4. Global Leukapheresis Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions

5. Leukapheresis Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Number of Voluntary Blood Donors
5.1.2 Increasing Incidence of Hematologic Diseases
5.1.3 Surge in Elderly Population
5.2 Key Market Restraints
5.2.1 High Cost of Leukapheresis
5.3 Key Market Opportunities
5.3.1 Growth Opportunities in Emerging Economies
5.4 Future Trends
5.4.1 Developments in Therapeutic Apheresis
5.5 Impact Analysis

6. Leukapheresis Market - Global Analysis
6.1 Global Leukapheresis Market Revenue Forecast and Analysis
6.2 Global Leukapheresis Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Leukapheresis Market Analysis and forecasts to 2028 - Product Type
7.1 Overview
7.2 Global Leukapheresis Market Share by Product Type 2021 & 2028 (%)
7.3 Leukapheresis Devices
7.3.1 Overview
7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.1 Apheresis Devices
7.3.2.1.1 Overview
7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.2 Leukapheresis Columns and Cell Separators
7.3.2.2.1 Overview
7.3.2.2.2 Leukapheresis Columns and Cell Separators Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.3 Leukoreduction Filters
7.3.2.3.1 Overview
7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Leukapheresis Disposables
7.4.1 Overview
7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Mn)

8. Leukapheresis Market Analysis and Forecasts TO 2028 - Application
8.1 Overview
8.2 Global Leukapheresis Market Share by Application 2021 & 2028 (%)
8.3 Research Applications
8.3.1 Overview
8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Therapeutic Applications
8.4.1 Overview
8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Mn)

9. Leukapheresis Market Analysis and Forecasts TO 2028 - End-User
9.1 Overview
9.2 Global Leukapheresis Market Share by End-User 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Blood Component Providers and Blood Centers
9.4.1 Overview
9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Mn)
9.6 Hospitals and Transfusion Centers
9.6.1 Overview
9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Mn)

10. Global Leukapheresis Market - Geographic Analysis

11. Impact of COVID-19 Pandemic on Global Leukapheresis Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Leukapheresis Market- Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview

13. Company Profiles
13.1 Asahi Kasei Corporation
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Haemonetics Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Terumo Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 HemaCare
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Macopharma
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AllCells
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 STEMEXPRESS
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 BioIVT
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/kbmz7r

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting